Literature DB >> 12186672

Rifaximin: a nonabsorbed antimicrobial as a new tool for treatment of travelers' diarrhea.

R Steffen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 12186672     DOI： 10.1111/j.1708-8305.2001.tb00545.x

Source DB:  PubMed          Journal:  J Travel Med        ISSN： 1195-1982            Impact factor:   8.490


× No keyword cloud information.
  4 in total

Review 1.  Rifaximin: a review of its use in the management of traveller's diarrhoea.

Authors:  Gayle W Robins; Keri Wellington
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Diagnosis and treatment of bacterial diarrhea.

Authors:  James V Lawler; Mark R Wallace
Journal:  Curr Gastroenterol Rep       Date:  2003-08

Review 3.  Safety and tolerability of the antibacterial rifaximin in the treatment of travellers' diarrhoea.

Authors:  Charles D Ericsson
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 4.  Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease.

Authors:  Sebastiaan P van Kessel; Sahar El Aidy
Journal:  Front Neurol       Date:  2019-10-15       Impact factor: 4.003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.